- Home
- SNBR vs CMPX Comparison
SNBR vs CMPX Comparison
Compare SNBR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- CMPX
- Stock Information
- Founded
- SNBR 1987
- CMPX 2014
- Country
- SNBR United States
- CMPX United States
- Employees
- SNBR N/A
- CMPX N/A
- Industry
- SNBR Home Furnishings
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- SNBR Consumer Discretionary
- CMPX Health Care
- Exchange
- SNBR Nasdaq
- CMPX Nasdaq
- Market Cap
- SNBR 399.8M
- CMPX 408.6M
- IPO Year
- SNBR 1998
- CMPX N/A
- Fundamental
- Price
- SNBR $6.86
- CMPX $2.24
- Analyst Decision
- SNBR Hold
- CMPX Strong Buy
- Analyst Count
- SNBR 3
- CMPX 7
- Target Price
- SNBR $12.00
- CMPX $12.43
- AVG Volume (30 Days)
- SNBR 1.1M
- CMPX 1.8M
- Earning Date
- SNBR 03-05-2025
- CMPX 05-12-2025
- Dividend Yield
- SNBR N/A
- CMPX N/A
- EPS Growth
- SNBR N/A
- CMPX N/A
- EPS
- SNBR N/A
- CMPX N/A
- Revenue
- SNBR $1,682,296,000.00
- CMPX $850,000.00
- Revenue This Year
- SNBR $4.50
- CMPX $47.65
- Revenue Next Year
- SNBR $3.07
- CMPX $3,909.48
- P/E Ratio
- SNBR N/A
- CMPX N/A
- Revenue Growth
- SNBR N/A
- CMPX N/A
- 52 Week Low
- SNBR $5.94
- CMPX $0.77
- 52 Week High
- SNBR $20.75
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- SNBR 35.45
- CMPX 44.45
- Support Level
- SNBR $5.94
- CMPX $2.18
- Resistance Level
- SNBR $6.79
- CMPX $2.17
- Average True Range (ATR)
- SNBR 0.67
- CMPX 0.22
- MACD
- SNBR 0.29
- CMPX -0.02
- Stochastic Oscillator
- SNBR 58.60
- CMPX 68.16
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.